Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALIGNERCO is a direct-to-consumer teledentistry and dental device company focused on affordable at-home clear aligner treatment. The company sells custom clear aligners, retainers, impression kits, whitening products, and related oral-care offerings, with treatment plans reviewed remotely by U.S.-licensed dental professionals. Its business is centered on mild-to-moderate orthodontic correction rather than drug development, and it operates as a commercial-stage dental brand rather than a biotech or pharmaceutical pipeline company. ALIGNERCO appears to market primarily in the United States and emphasizes lower-cost orthodontic care, remote monitoring, and home delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALIGNERCO.